Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues
- PMID: 25426797
- PMCID: PMC4281103
- DOI: 10.1021/jm501521d
Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues
Abstract
The neoclerodane diterpene salvinorin A, found in the leaves of Salvia divinorum, is a potent κ-opioid receptor agonist, making it an attractive scaffold for development into a treatment for substance abuse. Although several successful semisynthetic studies have been performed to elucidate structure-activity relationships, the lack of analogues with substitutions to the furan ring of salvinorin A has prevented a thorough understanding of its role in binding to the κ-opioid receptor. Herein we report the synthesis of several salvinorin A derivatives with modified furan rings. Evaluation of these compounds in a functional assay indicated that sterically less demanding substitutions are preferred, suggesting the furan ring is bound in a congested portion of the binding pocket. The most potent of the analogues successfully reduced drug-seeking behavior in an animal model of drug-relapse without producing the sedation observed with other κ-opioid agonists.
Figures








Similar articles
-
Opioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin A.J Nat Prod. 2011 Apr 25;74(4):718-26. doi: 10.1021/np1007872. Epub 2011 Feb 21. J Nat Prod. 2011. PMID: 21338114 Free PMC article.
-
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analogues.J Med Chem. 2007 Jul 26;50(15):3596-603. doi: 10.1021/jm070393d. Epub 2007 Jun 20. J Med Chem. 2007. PMID: 17580847
-
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.Phytochemistry. 2017 May;137:9-14. doi: 10.1016/j.phytochem.2017.02.001. Epub 2017 Feb 10. Phytochemistry. 2017. PMID: 28190678
-
Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.Pharmacol Rev. 2011 Jun;63(2):316-47. doi: 10.1124/pr.110.003244. Epub 2011 Mar 28. Pharmacol Rev. 2011. PMID: 21444610 Free PMC article. Review.
-
Salvinorin A: from natural product to human therapeutics.Mol Interv. 2006 Oct;6(5):257-65. doi: 10.1124/mi.6.5.7. Mol Interv. 2006. PMID: 17035666 Review.
Cited by
-
Gold(III)-Catalyzed Propargylic Substitution Reaction Followed by Cycloisomerization for Synthesis of Poly-Substituted Furans from N-Tosylpropargyl Amines with 1,3-Dicarbonyl Compounds.Molecules. 2024 Jan 11;29(2):378. doi: 10.3390/molecules29020378. Molecules. 2024. PMID: 38257291 Free PMC article.
-
Therapeutic Potential of Salvinorin A and Its Analogues in Various Neurological Disorders.Transl Perioper Pain Med. 2022;9(2):452-457. Epub 2022 Jun 29. Transl Perioper Pain Med. 2022. PMID: 35959414 Free PMC article. No abstract available.
-
The Intriguing Effects of Substituents in the N-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of "Tail Wags Dog" Experiments.Molecules. 2020 Jun 6;25(11):2640. doi: 10.3390/molecules25112640. Molecules. 2020. PMID: 32517185 Free PMC article.
-
Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Identification of a Potent and Centrally Acting μ Opioid Analgesic with Reduced Abuse Liability.J Med Chem. 2016 Dec 22;59(24):11027-11038. doi: 10.1021/acs.jmedchem.6b01235. Epub 2016 Dec 13. J Med Chem. 2016. PMID: 27958743 Free PMC article.
-
Targeting α1- and α2-adrenergic receptors as a countermeasure for fentanyl-induced locomotor and ventilatory depression.Environ Toxicol Pharmacol. 2024 Sep;110:104527. doi: 10.1016/j.etap.2024.104527. Epub 2024 Aug 4. Environ Toxicol Pharmacol. 2024. PMID: 39106924
References
-
- Mansour A.; Fox C. A.; Burke S.; Meng F.; Thompson R. C.; Akil H.; Watson S. J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study. J. Compar. Neurol. 1994, 350, 412–438. - PubMed
-
- Mansour A.; Fox C. A.; Meng F.; Akil H.; Watson S. J. κ1 Receptor mRNA distribution in the rat CNS: Comparison to κ receptor binding and prodynorphin mRNA. Mol. Cell. Neurosci. 1994, 5, 124–144. - PubMed
-
- Minami M.; Satoh M. Molecular biology of the opioid receptors: Structures, functions and distributions. Neurosci. Res. 1995, 23, 121–145. - PubMed
-
- Preti A. New developments in the pharmacotherapy of cocaine abuse. Addict. Biol. 2007, 12, 133–151. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information